Many Americans not getting breast, cervical, colon cancer screenings
the ONA take:
According to a study published in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report, researchers have found that many Americans are not getting recommended screening tests for breast, cervical, and colon cancers.
Specifically, results showed that among adults in the age groups recommended for screening, approximately one in four women not up to date with breast cancer screening, one in five women were not up to date with cervical cancer screening, and two in five were not up to date with colon cancer screening.
Of note, colon cancer screening rates were stagnant from 2010 to 2013 and cervical cancer screening using the Pap test in women 21 to 65 years of age was lower in 2013 than in 2000. In addition, mammography screenings changed minimally from previous years.
"It is often difficult to get patients to comply with screening tests, especially when they are uninsured or underinsured," said Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City. However, healthcare providers need to convince patients that early screening can improve outcomes.
Many Americans are not getting recommended screening tests for breast, cervical, and colon cancers.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|